Remove Access Remove Book Remove Clinical Trials
article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

By uniting the strength of Open Book Extract’s quality innovation and custom product development with Radicle Science’s unbiased scientific rigor in natural products research, we can impact every stage of the product life cycle from ideation to validation. About Open Book Extracts. About Radicle Science. Headquartered in Roxboro, N.C.,

article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

He is the author of several bestselling books, including Spontaneous Healing (1995), Eating Well for Optimum Health (2000), and Healthy Aging (2007). We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. Dr. Weil: In most U.S.

Medicine 308
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

Dr. Goldstein: We don’t have clinical trials to say, yes this is definitively beneficial or detrimental for children. But we may be on the cusp of having those trials, which would be very exciting. As I discuss in my book, we have a saying, ‘Rule it in or rule it out’ We start low dose, and we titrate up.

article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

RoC also works to increase patients’ access to medical cannabis by helping U.S. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis. states pass relevant legislation and educating doctors about the power of cannabis medicine. The campaign drove hundreds of ORR registrations.

article thumbnail

I wrote a book about global cannabis laws, here is what I learned…

Cannabis Law Report

It took twelve months of research, investigations and interviews (and about five weeks of non-stop writing with some very late nights and a lot of coffee) to produce my book on cannabis law and regulation, which is out now with Bloomsbury Professional. It’s not quite full-steam-ahead-full-recreational just yet. Regulation.

Law 59
article thumbnail

Synergetic Press and MAPS Form Copublishing Partnership

Cannabis Law Report

As with MAPS, Synergetic Press has been a leading publisher of cutting-edge books in the field of psychedelics and consciousness. The collaboration rests in the mutually held value to make these authors’ knowledge more accessible to a broader world-market. Today, he and his team have succeeded at getting very far down that road.

Therapy 69
article thumbnail

Understanding the Current Legal Status of Psychedelics in the United States

Cannabis Law Report

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. If you read Michael Pollan’s latest book on psychedelic drugs, you are probably familiar with what are described as “underground therapists.” Schedule I.